Avivo was one of five companies selected for funding under the Government of Canada’s Life Sciences Fund to advance dual-use innovations and strengthen Canada’s industrial capacity.
Tag: transplantation
Research Saves Lives
Dr. Lori West honoured by Heart and Stroke Foundation
GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs
The successful transplant marks major progress towards more compatible, accessible organs for patients.
GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture
Twenty-one projects receive funding to develop new therapeutics, tools and solutions by uncovering the roles of biological sugars in health and disease.
Harnessing the power of carbohydrates to improve our health
A better understanding of complex molecules called glycans will bring us closer to disease treatments and innovative solutions to health challenges, say leading researchers.
Breaking boundaries in organ transplantation with 21st-century glycomics
GlycoNet investigators have developed a new diagnostic test that will advance organ transplantation and enable more transplants across blood type barriers, saving more lives.
GlycoNet researchers develop ‘ice inhibitors’ to protect cells during cryopreservation
New compounds could open more opportunities for vital medical treatments, organ and tissue transplants, and reproductive medicine.
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians.
Redefining compatibility in organ transplantation
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.